Terumo Aortic Announces US FDA Approval for TREO ... | 合法醫療器材資訊網

2020年5月5日—TheTREOstent-graftoffersbothsuprarenalandinfrarenalfixation,distributingthestent-graftfixationintwodifferentanatomicallevelswhich ...

Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted approval of the TREO™ Abdominal Aortic Stent-Graft System for sale in the United States for the treatment of patients with abdominal aortic aneurysms (AAA).

TREO is the only device commercially available for endovascular aneurysm repair (EVAR) with dual proximal fixation and lock stent technology offering physicians the next advancement in endovascular device solutions. It is a three-piece design featuring in situ limb adjustability and provides a wide range of aortic device configurations to specifically address the anatomy of each individual patient. TREO is designed for accurate, controlled and safe deployment; the exclusive proximal clasping mechanism and a unique leave-behind sheath simplify the procedure as highlighted in recent clinical studies.

Sc...